Contact Us
Search website   

» Back to All Publication Categories

Genetic Polymorphism and Genotyping

Ascendingitem name
Wang HP, Xie JJ, Zhang ZY, Ying Y, Zhu ZG and Mao P
(2005) [Study on polymorphisms of CYP3A5 gene and their clinical role] [Article in Chinese] Zhonghua Yi Xue Yi Chuan Xue Za Zhi 22:423-426.

Thompson EE, Kuttab-Boulos H, Witonsky D, Yang L, Roe BA and Di Rienzo A
(2004) CYP3A variation and the evolution of salt-sensitivity variants. Am J Hum Genet 75:1059-1069.

Lamba JK, Lin YS, Schuetz EG and Thummel KE
(2002) Genetic contribution to variable human CYP3A-mediated metabolism. Advanced Drug Delivery Reviews 54:1271-1294.

Ingelman-Sundberg M, Oscarson M and McLellan RA
(1999) Polymorphic human cytochrome P450 enzymes: an opportunity for individualized drug treatment. Trends Pharmacol Sci 20:342-349.

Wormhoudt LW, Commandeur JN and Vermeulen NP
(1999) Genetic polymorphisms of human N-acetyltransferase, cytochrome P450, glutathione-S-transferase, and epoxide hydrolase enzymes: relevance to xenobiotic metabolism and toxicity. Crit Rev Toxicol 29:59-124.

Kalow W
(1997) Pharmacogenetics in biological perspective. Pharmacol Rev 49:369-379.

Meyer UA and Zanger UM
(1997) Molecular mechanisms of genetic polymorphisms of drug metabolism. Annu Rev Pharmacol Toxicol 37:269-296.

» Back to All Publication Categories